Anti-oxidative and anti-inflammatory effects of cinnamaldehyde on protecting high glucose-induced damage in cultured dorsal root ganglion neurons of rats

被引:39
作者
Yang Dan [1 ]
Liang Xiao-chun [1 ]
Shi Yue [1 ]
Sun Qing [1 ]
Liu Di [1 ]
Liu Wei [1 ]
Zhang Hong [2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Tradit Chinese Med,Translat Med Ctr, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Cell Resource Ctr, Beijing 100005, Peoples R China
基金
中国国家自然科学基金;
关键词
nuclear factor-kappa B; nuclear factor erythroid 2-related factor 2; cinnamaldehyde; high glucose; dorsal root ganglion; EXPERIMENTAL DIABETIC-NEUROPATHY; NF-KAPPA-B; INDUCED OXIDATIVE STRESS; NRF2; INJURY; MECHANISMS; PATHWAY; CELLS; NEUROINFLAMMATION; COMPLICATIONS;
D O I
10.1007/s11655-015-2103-8
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective: To examine the mechanism underlying the beneficial role of cinnamaldehyde on oxidative damage and apoptosis in high glucose (HG)-induced dorsal root ganglion (DRG) neurons in vitro. HG-treated DRG neurons were developed as an in vitro model of diabetic neuropathy. The neurons were randomly divided into five groups: the control group, the HG group and the HG groups treated with 25, 50 and 100 nmol/L cinnamaldehyde, respectively. Cell viability was examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and apoptosis rate was evaluated by the in situ TdT-mediated dUTP nick end labeling (TUNEL) assay. The intracellular level of reactive oxygen species (ROS) was measured with flow cytometry. Expression of nuclear factor-kappa B (NF-kappa B), inhibitor of B-kappa (I kappa B), phosphorylated I kappa B (p-I kappa B), tumor necrosis factor (TNF)(-alpha), interleukin-6 (IL-6) and caspase-3 were determined by western blotting and real-time quantitative reverse transcription polymerase chain reaction (RT-PCR). Expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and hemeoxygenase-1 (HO-1) were also measured by western blotting. Cinnamaldehyde reduced HG-induced loss of viability, apoptosis and intracellular generation of ROS in the DRG neurons via inhibiting NF-kappa B activity. The western blot assay results showed that the HG-induced elevated expressions of NF-kappa B, I kappa B and p-I kappa B were remarkably reduced by cinnamaldehyde treatment in a dose-dependent manner (P < 0.01). The HG-induced over-expression of NF-kappa B p65 mRNA was remarkably attenuated after cinnamaldehyde treatment in a dose-dependent manner (P < 0.01). However, the expressions of Nrf2 and HO-1 were not upregulated. Treatment with cinnamaldehyde not only attenuated caspase-3 activation and the caspase cleavage cascade in DRG neurons, but also lowered the elevated IL-6, TNF-alpha, cyclo-oxygenase and inducible nitric oxide synthase levels, indicating a reduction in inflammatory damage. Cinnamaldehyde protected DRG neurons from the deleterious effects of HG through inactivation of NF-kappa B pathway but not through activation of Nrf2/HO-1. And thus cinnamaldehyde may have potential application as a treatment for DPN.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 39 条
[1]   Heme oxygenase-1 gene therapy: Recent advances and therapeutic applications [J].
Abraham, Nader G. ;
Asija, Amit ;
Drummond, George ;
Peterson, Stephen .
CURRENT GENE THERAPY, 2007, 7 (02) :89-108
[2]   Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study [J].
Albers, James W. ;
Herman, William H. ;
Pop-Busui, Rodica ;
Feldman, Eva L. ;
Martin, Catherine L. ;
Cleary, Patricia A. ;
Waberski, Barbara H. ;
Lachin, John M. .
DIABETES CARE, 2010, 33 (05) :1090-1096
[3]  
Babu PS, 2007, PHYTOMEDICINE, V14, P15, DOI 10.1016/j.phymed.2006.11.005
[4]   Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily [J].
Bierhaus, A ;
Haslbeck, KM ;
Humpert, PM ;
Liliensiek, B ;
Dehmer, T ;
Morcos, M ;
Sayed, AAR ;
Andrassy, M ;
Schiekofer, S ;
Schneider, JG ;
Schulz, JB ;
Heuss, D ;
Neundörfer, B ;
Dierl, S ;
Huber, J ;
Tritschler, H ;
Schmidt, AM ;
Schwaninger, M ;
Haering, HU ;
Schleicher, E ;
Kasper, M ;
Stern, DM ;
Arnold, B ;
Nawroth, PP .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (12) :1741-1751
[5]   Diabetic neuropathies - A statement by the American Diabetes Association [J].
Boulton, AJM ;
Vinik, AI ;
Arezzo, JC ;
Bril, V ;
Feldman, EL ;
Freeman, R ;
Malik, RA ;
Maser, RE ;
Sosenko, JM ;
Ziegler, D .
DIABETES CARE, 2005, 28 (04) :956-962
[6]   The pathobiology of diabetic complications - A unifying mechanism [J].
Brownlee, M .
DIABETES, 2005, 54 (06) :1615-1625
[7]   Pro-inflammatory mechanisms in diabetic neuropathy: Focus on the nuclear factor kappa B pathway [J].
Cameron, Norman E. ;
Cotter, Mary A. .
CURRENT DRUG TARGETS, 2008, 9 (01) :60-67
[8]   Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling [J].
Chao, Louis Kuoping ;
Hua, Kuo-Feng ;
Hsu, Hsien-Yeh ;
Cheng, Sen-Sung ;
Lin, I-Fan ;
Chen, Chia-Jung ;
Chen, Shui-Tein ;
Chang, Shang-Tzen .
FOOD AND CHEMICAL TOXICOLOGY, 2008, 46 (01) :220-231
[9]   Diabetic neuropathy: Mechanisms to management [J].
Edwards, James L. ;
Vincent, Andrea M. ;
Cheng, Hsinlin T. ;
Feldman, Eva L. .
PHARMACOLOGY & THERAPEUTICS, 2008, 120 (01) :1-34
[10]   Mechanisms of disease: The oxidative stress theory of diabetic neuropathy [J].
Figueroa-Romero, Claudia ;
Sadidi, Mahdieh ;
Feldman, Eva L. .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2008, 9 (04) :301-314